Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-g78kv Total loading time: 0 Render date: 2024-07-28T14:24:23.656Z Has data issue: false hasContentIssue false

Lymphangioleiomyomatosis

Published online by Cambridge University Press:  25 February 2010

Andrew Planner
Affiliation:
John Radcliffe Hospital, Oxford
Mangerira Uthappa
Affiliation:
Stoke Mandeville Hospital
Rakesh Misra
Affiliation:
Buckinghamshire Hospitals NHS Trust
Get access

Summary

Characteristics

  • This is a rare disease of unknown cause characterised by the presence of abnormal smooth muscle proliferation of the pulmonary interstitium, particularly in the bronchioles, pulmonary vessels and lymphatics.

  • Exclusively affects women of a child-bearing age.

  • Associated with chylous ascites, fatty liver and renal angiomyolipomas.

Clinical features

  • Progressive exertional dyspnoea.

  • Haemoptysis.

  • Restrictive lung function and hypoxia.

  • Increase in symptoms during pregnancy and on the oral contraceptive pill.

Radiological features

  • CXR – coarse reticular interstitial pattern with cyst formation on the background of large volume lungs. There is a common association with chylous pleural effusions (70%), pneumothoraces (40%) and mediastinal lymphadenopathy.

  • HRCT – numerous random thin-walled cysts of varying size and relatively regular shape. Bronchovascular bundles at edge of cyst. Lymphadenopathy, pleural effusions and pneumothoraces. Dilated thoracic duct.

  • Long-standing cases may develop pulmonary arterial hypertension with enlargement of the central pulmonary arteries.

Differential diagnosis

  • Langerhan's cell histiocytosis – male smokers, with upper zone predisposition and more cyst irregularity.

  • Tuberous sclerosis – rare. Other characteristic abnormalities present.

  • Emphysema – smokers. No wall to the emphysematous bullae.

  • Neurofibromatosis – rare with musculoskeletal and neurogenic abnormalities.

  • Lung fibrosis (e.g. UIP). Basal fibrosis and honeycombing.

Management

  • Lung biopsy may be required to confirm the diagnosis.

  • No specific treatment.

  • 10-year survival is 75%.

  • Progression to pulmonary insufficiency and arterial hypertension.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×